Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian share markets remain buoyant
Fri, 7 Feb 01:30 pm

Indian share markets pared early gains but continued to trade higher in the post-noon trading session. Majority of the sectoral indices are trading in the green with metal, pharma and realty witnessing maximum buying interest. Only FMCG, IT and consumer durable stocks are trading in the red.

BSE-Sensex is up 40 points and NSE-Nifty is trading 14 points up. BSE Mid Cap is trading 0.6% up and BSE Small Cap index is trading up by 0.5%. The rupee is trading at 62.2 to the US dollar.

Majority of the automobile stocks are trading in the green with Bajaj Auto and Escorts being among major gainers whereas TVS Motors and Eicher Motors are the biggest losers. As per a leading financial daily, Tata Motors is aiming to achieve 15% growth in revenues from the defence business over the next two years. The company is trying to expand its defence business in ASEAN countries such as Thailand, Malaysia and Indonesia. The company recently signed a distributorship agreement for defence vehicles for Indonesia. Tata Motors has been in association with India's off-road defence and security forces since 1958. Tata Motors stock is presently trading up 0.8%.

Most of the Indian pharma stocks are trading firm with Aurobindo Pharma and Biocon leading the pack of gainers while Panacea Biotech and Ranbaxy Labs are a few stocks trading in the red. As per a leading business daily, the Indian arm of the Swiss pharma company Roche has sued Biocon and US generic company Mylan for launching the world's first biosimilar version of the breast cancer drug Herceptin (Trastuzumab). The company has also sued the Drug Controller General of India for giving approval for the launch of the drug. Roche had relinquished its patent on Herceptin in India last year. The Delhi High Court has issued a restraint order on Mylan and Biocon against relying or referring to Herceptin or any other data for selling or promoting their brands Canmab (Biocon) and Hertaz (Mylan) till the next hearing. According to Roche, both Biocon and Mylan have not followed the due process as per guidelines on getting approvals for biologics in India. Biocon stock is trading up 3.2%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian share markets remain buoyant". Click here!

  

Related Views on News

TATA MOTORS Announces Quarterly Results (2QFY20); Net Profit Up 117.4% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, TATA MOTORS has posted a net profit of Rs 2 bn (up 117.4% YoY). Sales on the other hand came in at Rs 654 bn (down 9.3% YoY). Read on for a complete analysis of TATA MOTORS's quarterly results.

TATA MOTORS Announces Quarterly Results (1QFY20); Net Profit Down 58.4% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, TATA MOTORS has posted a net profit of Rs 34 bn (down 58.4% YoY). Sales on the other hand came in at Rs 615 bn (down 8.4% YoY). Read on for a complete analysis of TATA MOTORS's quarterly results.

TATA MOTORS 2018-19 Annual Report Analysis (Annual Result Update)

Jul 5, 2019 | Updated on Jul 5, 2019

Here's an analysis of the annual report of TATA MOTORS for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TATA MOTORS. Also includes updates on the valuation of TATA MOTORS.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE AUTO


Mar 3, 2021 (Close)

S&P BSE AUTO 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS